Low‐Dose Intravenous Challenge Testing to Neuromuscular Blocking Agents: A Safe and Effective Approach to the Investigation of Perioperative Anaphylaxis
Summary Low‐dose NMBA challenges are safe and well tolerated when performed in a suitable setting. 10% of a standard dose was sufficient to provoke allergic symptoms in two patients with NMBA allergy.
Authors
- Joshua Gladman (ORCID: https://orcid.org/0000-0002-7846-1291)
- Louise Young (ORCID: https://orcid.org/0000-0003-1893-2378)
- Linda Nel (ORCID: https://orcid.org/0009-0007-2955-7274)
- Efrem Eren (ORCID: https://orcid.org/0000-0002-7815-6094)
- Xi Ying Soo (ORCID: https://orcid.org/0009-0008-2383-1516)
- Luc Bugeja (ORCID: https://orcid.org/0009-0003-3092-8336)
Institutions
- University Hospital Southampton NHS Foundation Trust (GB)
Publication Details
- Journal
- Clinical & Experimental Allergy
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1111/cea.70198
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00